Scientist-entrepreneurs often feel as if nobody knows their product better than they do.
Attempts to engineer contact lenses that also elute therapeutic drugs face hurdles in both the world of lenses and of drugs.
Preparation for preclinical stages of drug development could have implications for postmarketing success.
Positive statistical correlations were identified